From Roche’s $1.4 billion licensing deal to AstraZeneca’s presidential symposium and an avalanche of clinical readouts, antibody-drug conjugates dominated Europe’s leading cancer conference over the ...

While the race is on to develop antibody-drug conjugate (ADC) cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma ...

The AC performance of an analog-to-digital converter depends on its architecture. In part 3 of this series, we discussed the integral nonlinearity (INL) error of an ...

After flexing its antibody-drug conjugate bona fides at last year’s American Society of Clinical Oncology (ASCO) conference, AbbVie is advancing its solid tumor ambitions with a new FDA green light.

Abstract: This paper presents two fully standard-cell-based synthesizable Successive Approximation Register Analog-to-Digital Converters (SAR ADCs) and the automated layout generation framework. The ...

Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...

Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate (ADC), trumpeting a 100% complete response rate but also reporting safety signals that informed the decision to take the low ...

ABSTRACT: A 14-bit successive approximation analog-to-digital converter (SAR ADC) with capacitive calibration has been designed based on the SMIC. 18 μm CMOS process. The overall architecture is in ...

1 School of Automation and Information Engineering, Sichuan University of Science and Engineering, Yibin, China. 2 Sichuan Key Laboratory of Artificial Intelligence, Yibin, China. A 14-bit successive ...